Virtual CLE today focuses on patents, politics of COVID-19

  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

The Indiana University Maurer School of Law, Eli Lilly & Co. and Roche are partnering for a virtual discussion today, “Pharmaceutical Innovations: Patents and the Politics of COVID-19.”

Panelists include Joe Allen of Ohio-based Allen & Associates, who was a staff author of the 1980 Bayh-Dole Act regulating intellectual property arising from government-funded research. Other panelists are Patty Martin, CEO of Indiana BioCrossroads; Robert Sahr, biotechnology counsel at Wolf Greenfield & Sacks P.C. in Boston; and Jacob Sherkow, a professor at the University of Illinois College of Law whose bio says his research “focuses on the legal and ethical implications of advanced biotechnologies, especially as related to intellectual property.”

Elil Lilly patent counsel Danica Hostettler will moderate the discussion.

The virtual panel is free and will be from noon-1:30 p.m. today, but registration is required. Registration details are available here. 

The program has been approved for 1.5 hours of continuing legal education credit.

Please enable JavaScript to view this content.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}